Clinical Guidelines

Optical Genome Mapping Detects Additional Genetic Variants in Nearly 20% of Individuals With Acute Leukemia

By providing a single, genome-wide view, optical genome mapping captured genetic changes across the full spectrum of size and complexity, overcoming limitations in resolution and scope in conventional...

Share

A study published in The Journal of Molecular Diagnostics by Tara Spence et al. reveals that optical genome mapping (OGM) significantly enhances the detection of genetic alterations in acute leukemia patients. In a cohort of 200 patients, OGM identified over 640 genetic variants, surpassing the 444 detected by standard tests, with nearly 20% of cases revealing critical abnormalities previously missed. While not a complete replacement for existing tests, OGM complements them, improving diagnostics and treatment planning by offering a comprehensive genomic view.

Original Source(s)

Optical Genome Mapping Detects Additional Genetic Variants in Nearly 20% of Individuals With Acute Leukemia

  • by The ASCO Post Staff

  • March 16, 2026

Related Content

Adjusted Calcium Is Lying — And Labs Keep Printing It

Choy et al. argue it's time to stop trusting a number that's been unreliable for fifty years.

Vitamin D Deficiency and Bone Disease

Review finds limited evidence that common vitamin D deficiency cutoffs consistently reflect bone disease risk in community dwellers

Value-based Healthcare: The Vision

Founding members of the Santa Fe Project discuss the role of pathology in improving population-level health